Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026)

Johnson & Johnson (JNJ) posted Interest & Investment Income of $229.0 million for Q1 2026, down 3.38% sequentially from $237.0 million in Q4 2025, and down 31.02% YoY from $332.0 million in Q1 2025.

Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Interest & Investment Income data on file, last reported at $229.0 million in Q1 2026.

  • Quarterly Interest & Investment Income fell 31.02% year-over-year to $229.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $953.0 million (down 26.69% YoY) and the FY2025 annual result came in at $1.1 billion, down 20.72% from the prior year.
  • Interest & Investment Income slipped to $229.0 million in Q1 2026 per JNJ's latest filing, from $237.0 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $450.0 million in Q1 2023, with the low at $22.0 million in Q2 2022.
  • Average Interest & Investment Income over 5 years is $268.5 million, with a median of $281.0 million recorded in 2024.
  • Year-over-year, Interest & Investment Income soared 1053.85% in 2022 and sank 34.18% in 2025.
  • Johnson & Johnson's Interest & Investment Income stood at $150.0 million in 2022, then soared by 142.0% to $363.0 million in 2023, then retreated by 22.59% to $281.0 million in 2024, then fell by 15.66% to $237.0 million in 2025, then fell by 3.38% to $229.0 million in 2026.
  • Business Quant data shows JNJ's Interest & Investment Income at $229.0 million in Q1 2026, $237.0 million in Q4 2025, and $227.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 229.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -645.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 73.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 229.00 Mn
Dec 28, 2025 237.00 Mn
Sep 28, 2025 227.00 Mn
Jun 29, 2025 260.00 Mn
Mar 30, 2025 332.00 Mn
Dec 29, 2024 281.00 Mn
Sep 29, 2024 292.00 Mn
Jun 30, 2024 395.00 Mn
Mar 31, 2024 364.00 Mn
Dec 31, 2023 363.00 Mn
Oct 1, 2023 374.00 Mn
Jul 2, 2023 326.00 Mn
Apr 2, 2023 198.00 Mn
Jan 1, 2023 450.00 Mn
Oct 2, 2022 150.00 Mn
Jul 3, 2022 64.00 Mn
Apr 3, 2022 22.00 Mn
Oct 3, 2021 13.00 Mn
Jul 4, 2021 12.00 Mn
Apr 4, 2021 15.00 Mn